Categories: News

Intuitive BioTechnologies has Expanded Testing Capabilities

PASADENA, Calif., Feb. 6, 2025 /PRNewswire/ — Intuitive BioTechnologies LLC (IBT) is proud to announce they have added elemental analysis to their testing capabilities. IBT is now offering quantitative single or multi-element analysis as well as semi-quantitative screening. Using ICP-OES technology, IBT can quantify over 50 elements in a single measurement. Additionally, Agilent’s IntelliQuant software provides semi-quantitative data of abundant commonly detected elements found in each sample, enabling rapid method development. This technology helps reduce client’s cost and save valuable time and resources.

With its new addition, IBT can measure many elements down to 10 ppb and can even measure samples with up to 5% total dissolved solids. With the ability to test over 1000 samples a day, IBTs elemental analysis service comes with short turnaround time and competitive pricing. In adding to their current list of services, IBT can help meet your testing needs. “Whether you’re an early start-up performing discovery studies or an established company who needs to outsource lot release residuals testing, we’re here to help.” says Travis Jones, BD and Lab Manager, Intuitive Biotechnologies. “We want to help you get your product to the next step.”

About Intuitive BioTechnologies

IBT is a US service-based company that offers in-vitro biological and analytical tests. IBT’s goal is to offer affordable, rapid, and reliable testing services to the fast-growing life-science community. IBT offers its in-vitro biological and analytical tests for characterizing medical devices, therapeutics, and other regulated products. IBT works closely with their clients to ensure the appropriate tests are performed for each product. IBT also offers custom testing solutions to help companies transition between research, product development, and regulatory testing.  

For more information contact IBT
Website: IntuitiveBioTech.com
Phone: (719) 413-7292
Email: Flowcytometry@intuitvebiotech.com 

View original content:https://www.prnewswire.com/news-releases/intuitive-biotechnologies-has-expanded-testing-capabilities-302370618.html

SOURCE Intuitive Biotechnologies

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

4 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

6 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

6 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

6 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

6 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

6 hours ago